GHK-Cu
We've tested 544 samples of GHK-Cu sourced from 67 vendors between 22 Apr 2025 and 8 Jun 2026. Purity typically ranges from 99.60% to 99.97% (5th-95th percentile), and quantity typically diverges by up to +/-48% vs advertised value (95th percentile).
Take Action
Suggest A Vendor
Test GHK-Cu
Mail in a sample for free testing (US only, terms apply)
Vendors
Most recent GHK-Cu tests
Samples are tested in commercial labs
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Vendor | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 8 Jun 2026 | Qing Li Peptide | View | 50mg | (no batch claim) | 54.3mg | +8.6% | 99.90% | Oct 27, 2025 | No label / Silver crimp / White cap | Lab E | Public | |
| 8 Jun 2026 | Tianjin Ruiwang New Material Technology Co | View | 100mg | (no batch claim) | 88.7mg | -11.3% | 99.90% | March 3,2026 | (no data) | Lab E | Public | |
| 4 Jun 2026 | Lisa Biopeptide | View | 100mg | (no batch claim) | 93.2mg | -6.8% | 99.70% | 051826-100CU | White label / Silver crimp / Blue cap | Lab G | Public | |
| 2 Jun 2026 | Qing Li Peptide | View | 50mg | (no batch claim) | 46.4mg | -7.2% | 99.90% | March 6, 2026 | No label / Silver crimp / Blue cap | Lab E | Public | |
| 2 Jun 2026 | Shandong Aishi Biotechnology | View | 50mg | (no batch claim) | 48.1mg | -3.8% | 99.80% | March 29 2026 | No label / Silver crimp / Blue cap | Lab E | Public | |
| 2 Jun 2026 | Orbitrex Peptides | View | 50mg | 47.2mg | 49.9mg | +5.7% | 99.90% | GHK50526US | Green & Blue label / Green crimp / Blue cap | Lab E | Public | |
| 2 Jun 2026 | Shanghai ERP peptide Biotechnology | View | 100mg | (no batch claim) | 93.6mg | -6.4% | 99.90% | CU100 | No label / Silver crimp / Red cap | Lab E | Public | |
Corrections
- 30 May 2026: Nexaph
- Sample wu24pm7 was submitted with an incorrect declared potency of 50 mg. The requester later confirmed that a submission error had occurred. Following review of the associated purchase order, the intended potency was determined to be 100 mg, which is more consistent with the laboratory results obtained for this sample.
- 17 Nov 2025: Peptide Sciences
- Test results for sample rkh8jub were published from 31 Oct to 17 Nov 2025, but did not belong to Peptide Sciences: the sample was misidentified, and re-attributed to the correct vendor.
- 31 Jul 2025: Peptidology
- Peptidology ratings for GHK-Cu were updated from B to A, after taking into account the Batch IDs that are included on vials, but were initially not identified by Finnrick.
- 10 Jul 2025:
- Lab E tests published 10 Jul 2025: change in testing and analysis methodology on 15 GHK-Cu tests previously published in May and June. New COAs were issued by the lab, and test scores have been updated.























